Brinton Pharmaceuticals

PharmaceuticalsSeries BPune, Indiabrintonhealth.com

Latest round

Series B

Last raised

Jun 2019

Total raised

$5.7M

Investors

1

About Brinton Pharmaceuticals

Founded in 2014 and based in Pune, India, Brinton Pharmaceuticals Ltd. operates as a pharmaceutical company that researches and manufactures medicines for the treatment of skin disorders, women's health needs, bone-related diseases, infectious diseases and neurological disorders. Its products include Skinnova, Ovaline, Bonacare, Seedlings and Neuton.

Who invested in Brinton Pharmaceuticals

1 investor across 1 round

See all investors in Brinton Pharmaceuticals

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series B

    Jun 13, 2019

    Amount

    $5.7M

    Investors

    Locked

Questions about Brinton Pharmaceuticals

Who invested in Brinton Pharmaceuticals?

Brinton Pharmaceuticals has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Brinton Pharmaceuticals raised?

Brinton Pharmaceuticals has raised 1 venture round. Sign up free to see how much each round raised and the total.

When did Brinton Pharmaceuticals last raise money?

Brinton Pharmaceuticals's most recent round on record is a Series B, in Jun 2019.

What does Brinton Pharmaceuticals do?

Founded in 2014 and based in Pune, India, Brinton Pharmaceuticals Ltd.

Where is Brinton Pharmaceuticals headquartered?

Brinton Pharmaceuticals is headquartered in Pune, India.

Which VCs invest in companies like Brinton Pharmaceuticals?

Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back pharmaceuticals companies at Brinton Pharmaceuticals's stage. Their profiles are linked below.

Raising like Brinton Pharmaceuticals? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.